Clinical Trial Update: Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Subjects With Severe Hemophilia A [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating recombinant Factor VIII Fc fusion protein (rFVIIIFc) in previously treated patients with severe Hemophilia A completed with posted resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Recombinant Factor VIII Fc fusion protein (rFVIIIFc)

Snippet

Sponsor: Bioverativ Therapeutics Inc. | Conditions: Severe Hemophilia A | Phase 3 | Status: COMPLETED | Results posted: 2014-08-29